Navigen Announces FDA Clearance of its IND Application to Initiate First-in-Human Studies for CPT31, a Novel, D-peptide HIV Entry Inhibitor
December 10, 2019 08:00 ET
|
Navigen, Inc.
SALT LAKE CITY, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Navigen, Inc. announced today that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug application ("IND") for...
Rafael Pharmaceuticals Enters into Collaboration with the National Institutes of Health (NIH) to Test CPI-613® (devimistat) in Cytokine Independent (Acute) HTLV-1 Associated Adult T-cell Leukemia/Lymphoma
October 17, 2019 09:00 ET
|
Rafael Pharmaceutical Inc.
Cranbury, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that...
New Research to Confirm Why BrainHQ Exercises Work Across Diverse Populations
October 01, 2019 08:00 ET
|
Posit Science
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Posit Science, the maker of BrainHQ computerized brain exercises, has been awarded a federal grant to measure the impact of BrainHQ training on the...
National Institutes of Health Awards Morgan State University a Total of $35 Million in New Grant Funding for Research
August 09, 2019 11:04 ET
|
Morgan State University
Baltimore, Maryland, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Morgan State University has secured a total of $35 million in new grant awards from the National Institutes of Health (NIH), the world’s...
GeoVax Presents HIV Vaccine Study Data
July 24, 2019 09:00 ET
|
GeoVax, Inc.
Presentation Made at the 10th International AIDS Society Conference on HIV Science ATLANTA, GA, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome
June 18, 2019 16:30 ET
|
Retrophin, Inc.
SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the...
Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 9, 2019
May 01, 2019 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, May 01, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company focused on treating...
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
April 01, 2019 11:43 ET
|
Taconic Biosciences
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild...
Developing vaccines and therapies for the highly pathogenic Nipah and Hendra viruses
March 25, 2019 10:00 ET
|
Henry M. Jackson Foundation for the Advancement of Military Medicine
Bethesda, Maryland, March 25, 2019 (GLOBE NEWSWIRE) -- Bethesda, MD, March 20, 2019 – The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), along with Uniformed...
GTX Signs Collaboration Agreement with Flint Rehab
February 06, 2019 08:35 ET
|
GTX Corp
LOS ANGELES, CALIFORNIA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- GTX Corp (OTCQB: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS, human and asset tracking systems and wandering...